Global Molecular Diagnostics Systems Market Research Report 2023

Molecular Diagnostics Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Molecular Diagnostics Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Molecular Diagnostics Systems Market Report

1.1 Product Overview and Scope of Molecular Diagnostics Systems

1.2 Molecular Diagnostics Systems Segment by Type

1.2.1 Global Molecular Diagnostics Systems Market Value Comparison by Type (2023-2029)

1.2.2 PCR

1.2.3 Hybridization

1.2.4 DNA Sequencing

1.3 Molecular Diagnostics Systems Segment by Application

1.3.1 Global Molecular Diagnostics Systems Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Laboratories

1.4 Global Molecular Diagnostics Systems Market Size Estimates and Forecasts

1.4.1 Global Molecular Diagnostics Systems Revenue 2018-2029

1.4.2 Global Molecular Diagnostics Systems Sales 2018-2029

1.4.3 Global Molecular Diagnostics Systems Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2018-2023)

2.2 Global Molecular Diagnostics Systems Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Molecular Diagnostics Systems Average Price by Manufacturers (2018-2023)

2.4 Global Molecular Diagnostics Systems Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Molecular Diagnostics Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Molecular Diagnostics Systems, Product Type & Application

2.7 Molecular Diagnostics Systems Market Competitive Situation and Trends

2.7.1 Molecular Diagnostics Systems Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Molecular Diagnostics Systems Players Market Share by Revenue

2.7.3 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Molecular Diagnostics Systems Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Molecular Diagnostics Systems Global Molecular Diagnostics Systems Sales by Region: 2018-2029

3.2.1 Global Molecular Diagnostics Systems Sales by Region: 2018-2023

3.2.2 Global Molecular Diagnostics Systems Sales by Region: 2024-2029

3.3 Global Molecular Diagnostics Systems Global Molecular Diagnostics Systems Revenue by Region: 2018-2029

3.3.1 Global Molecular Diagnostics Systems Revenue by Region: 2018-2023

3.3.2 Global Molecular Diagnostics Systems Revenue by Region: 2024-2029

3.4 North America Molecular Diagnostics Systems Market Facts & Figures by Country

3.4.1 North America Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Molecular Diagnostics Systems Sales by Country (2018-2029)

3.4.3 North America Molecular Diagnostics Systems Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Molecular Diagnostics Systems Market Facts & Figures by Country

3.5.1 Europe Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Molecular Diagnostics Systems Sales by Country (2018-2029)

3.5.3 Europe Molecular Diagnostics Systems Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Molecular Diagnostics Systems Market Facts & Figures by Country

3.6.1 Asia Pacific Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Molecular Diagnostics Systems Sales by Country (2018-2029)

3.6.3 Asia Pacific Molecular Diagnostics Systems Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Molecular Diagnostics Systems Market Facts & Figures by Country

3.7.1 Latin America Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Molecular Diagnostics Systems Sales by Country (2018-2029)

3.7.3 Latin America Molecular Diagnostics Systems Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Molecular Diagnostics Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Molecular Diagnostics Systems Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Molecular Diagnostics Systems Sales by Country (2018-2029)

3.8.3 Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Molecular Diagnostics Systems Sales by Type (2018-2029)

4.1.1 Global Molecular Diagnostics Systems Sales by Type (2018-2023)

4.1.2 Global Molecular Diagnostics Systems Sales by Type (2024-2029)

4.1.3 Global Molecular Diagnostics Systems Sales Market Share by Type (2018-2029)

4.2 Global Molecular Diagnostics Systems Revenue by Type (2018-2029)

4.2.1 Global Molecular Diagnostics Systems Revenue by Type (2018-2023)

4.2.2 Global Molecular Diagnostics Systems Revenue by Type (2024-2029)

4.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Type (2018-2029)

4.3 Global Molecular Diagnostics Systems Price by Type (2018-2029)

5.1 Global Molecular Diagnostics Systems Sales by Application (2018-2029)

5.1.1 Global Molecular Diagnostics Systems Sales by Application (2018-2023)

5.1.2 Global Molecular Diagnostics Systems Sales by Application (2024-2029)

5.1.3 Global Molecular Diagnostics Systems Sales Market Share by Application (2018-2029)

5.2 Global Molecular Diagnostics Systems Revenue by Application (2018-2029)

5.2.1 Global Molecular Diagnostics Systems Revenue by Application (2018-2023)

5.2.2 Global Molecular Diagnostics Systems Revenue by Application (2024-2029)

5.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Application (2018-2029)

5.3 Global Molecular Diagnostics Systems Price by Application (2018-2029)

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Corporation Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Abbott Laboratories Molecular Diagnostics Systems Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Qiagen N.V.

6.2.1 Qiagen N.V. Corporation Information

6.2.2 Qiagen N.V. Description and Business Overview

6.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Qiagen N.V. Molecular Diagnostics Systems Product Portfolio

6.2.5 Qiagen N.V. Recent Developments/Updates

6.3 Roche Diagnostics

6.3.1 Roche Diagnostics Corporation Information

6.3.2 Roche Diagnostics Description and Business Overview

6.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Roche Diagnostics Molecular Diagnostics Systems Product Portfolio

6.3.5 Roche Diagnostics Recent Developments/Updates

6.4 Hologic, Inc.

6.4.1 Hologic, Inc. Corporation Information

6.4.2 Hologic, Inc. Description and Business Overview

6.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Hologic, Inc. Molecular Diagnostics Systems Product Portfolio

6.4.5 Hologic, Inc. Recent Developments/Updates

6.5 Grifols

6.5.1 Grifols Corporation Information

6.5.2 Grifols Description and Business Overview

6.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Grifols Molecular Diagnostics Systems Product Portfolio

6.5.5 Grifols Recent Developments/Updates

6.6 Siemens Healthcare

6.6.1 Siemens Healthcare Corporation Information

6.6.2 Siemens Healthcare Description and Business Overview

6.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Siemens Healthcare Molecular Diagnostics Systems Product Portfolio

6.6.5 Siemens Healthcare Recent Developments/Updates

6.7 Becton, Dickinson and Company

6.6.1 Becton, Dickinson and Company Corporation Information

6.6.2 Becton, Dickinson and Company Description and Business Overview

6.6.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Becton, Dickinson and Company Molecular Diagnostics Systems Product Portfolio

6.7.5 Becton, Dickinson and Company Recent Developments/Updates

6.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)

6.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information

6.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview

6.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Portfolio

6.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates

6.9 Biomérieux Sa

6.9.1 Biomérieux Sa Corporation Information

6.9.2 Biomérieux Sa Description and Business Overview

6.9.3 Biomérieux Sa Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Biomérieux Sa Molecular Diagnostics Systems Product Portfolio

6.9.5 Biomérieux Sa Recent Developments/Updates

6.10 Cepheid Inc

6.10.1 Cepheid Inc Corporation Information

6.10.2 Cepheid Inc Description and Business Overview

6.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Cepheid Inc Molecular Diagnostics Systems Product Portfolio

6.10.5 Cepheid Inc Recent Developments/Updates

7.1 Molecular Diagnostics Systems Industry Chain Analysis

7.2 Molecular Diagnostics Systems Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Molecular Diagnostics Systems Production Mode & Process

7.4 Molecular Diagnostics Systems Sales and Marketing

7.4.1 Molecular Diagnostics Systems Sales Channels

7.4.2 Molecular Diagnostics Systems Distributors

7.5 Molecular Diagnostics Systems Customers

8.1 Molecular Diagnostics Systems Industry Trends

8.2 Molecular Diagnostics Systems Market Drivers

8.3 Molecular Diagnostics Systems Market Challenges

8.4 Molecular Diagnostics Systems Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Molecular Diagnostics Systems Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Molecular Diagnostics Systems Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Molecular Diagnostics Systems Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Molecular Diagnostics Systems Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Molecular Diagnostics Systems Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Molecular Diagnostics Systems Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Molecular Diagnostics Systems Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Molecular Diagnostics Systems, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Molecular Diagnostics Systems, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Molecular Diagnostics Systems, Product Type & Application

    Table 12. Global Key Manufacturers of Molecular Diagnostics Systems, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Molecular Diagnostics Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Molecular Diagnostics Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Molecular Diagnostics Systems Sales by Region (2018-2023) & (K Units)

    Table 18. Global Molecular Diagnostics Systems Sales Market Share by Region (2018-2023)

    Table 19. Global Molecular Diagnostics Systems Sales by Region (2024-2029) & (K Units)

    Table 20. Global Molecular Diagnostics Systems Sales Market Share by Region (2024-2029)

    Table 21. Global Molecular Diagnostics Systems Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Molecular Diagnostics Systems Revenue Market Share by Region (2018-2023)

    Table 23. Global Molecular Diagnostics Systems Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Molecular Diagnostics Systems Revenue Market Share by Region (2024-2029)

    Table 25. North America Molecular Diagnostics Systems Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Molecular Diagnostics Systems Sales by Country (2018-2023) & (K Units)

    Table 27. North America Molecular Diagnostics Systems Sales by Country (2024-2029) & (K Units)

    Table 28. North America Molecular Diagnostics Systems Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Molecular Diagnostics Systems Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Molecular Diagnostics Systems Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Molecular Diagnostics Systems Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Molecular Diagnostics Systems Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Molecular Diagnostics Systems Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Molecular Diagnostics Systems Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Molecular Diagnostics Systems Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Molecular Diagnostics Systems Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Molecular Diagnostics Systems Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Molecular Diagnostics Systems Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Molecular Diagnostics Systems Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Molecular Diagnostics Systems Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Molecular Diagnostics Systems Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Molecular Diagnostics Systems Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Molecular Diagnostics Systems Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Molecular Diagnostics Systems Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Molecular Diagnostics Systems Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Molecular Diagnostics Systems Sales (K Units) by Type (2018-2023)

    Table 51. Global Molecular Diagnostics Systems Sales (K Units) by Type (2024-2029)

    Table 52. Global Molecular Diagnostics Systems Sales Market Share by Type (2018-2023)

    Table 53. Global Molecular Diagnostics Systems Sales Market Share by Type (2024-2029)

    Table 54. Global Molecular Diagnostics Systems Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Molecular Diagnostics Systems Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Molecular Diagnostics Systems Revenue Market Share by Type (2018-2023)

    Table 57. Global Molecular Diagnostics Systems Revenue Market Share by Type (2024-2029)

    Table 58. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Molecular Diagnostics Systems Sales (K Units) by Application (2018-2023)

    Table 61. Global Molecular Diagnostics Systems Sales (K Units) by Application (2024-2029)

    Table 62. Global Molecular Diagnostics Systems Sales Market Share by Application (2018-2023)

    Table 63. Global Molecular Diagnostics Systems Sales Market Share by Application (2024-2029)

    Table 64. Global Molecular Diagnostics Systems Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Molecular Diagnostics Systems Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Molecular Diagnostics Systems Revenue Market Share by Application (2018-2023)

    Table 67. Global Molecular Diagnostics Systems Revenue Market Share by Application (2024-2029)

    Table 68. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2024-2029)

    Table 70. Abbott Laboratories Corporation Information

    Table 71. Abbott Laboratories Description and Business Overview

    Table 72. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Abbott Laboratories Molecular Diagnostics Systems Product

    Table 74. Abbott Laboratories Recent Developments/Updates

    Table 75. Qiagen N.V. Corporation Information

    Table 76. Qiagen N.V. Description and Business Overview

    Table 77. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Qiagen N.V. Molecular Diagnostics Systems Product

    Table 79. Qiagen N.V. Recent Developments/Updates

    Table 80. Roche Diagnostics Corporation Information

    Table 81. Roche Diagnostics Description and Business Overview

    Table 82. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Roche Diagnostics Molecular Diagnostics Systems Product

    Table 84. Roche Diagnostics Recent Developments/Updates

    Table 85. Hologic, Inc. Corporation Information

    Table 86. Hologic, Inc. Description and Business Overview

    Table 87. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Hologic, Inc. Molecular Diagnostics Systems Product

    Table 89. Hologic, Inc. Recent Developments/Updates

    Table 90. Grifols Corporation Information

    Table 91. Grifols Description and Business Overview

    Table 92. Grifols Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Grifols Molecular Diagnostics Systems Product

    Table 94. Grifols Recent Developments/Updates

    Table 95. Siemens Healthcare Corporation Information

    Table 96. Siemens Healthcare Description and Business Overview

    Table 97. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Siemens Healthcare Molecular Diagnostics Systems Product

    Table 99. Siemens Healthcare Recent Developments/Updates

    Table 100. Becton, Dickinson and Company Corporation Information

    Table 101. Becton, Dickinson and Company Description and Business Overview

    Table 102. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Becton, Dickinson and Company Molecular Diagnostics Systems Product

    Table 104. Becton, Dickinson and Company Recent Developments/Updates

    Table 105. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information

    Table 106. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview

    Table 107. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product

    Table 109. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates

    Table 110. Biomérieux Sa Corporation Information

    Table 111. Biomérieux Sa Description and Business Overview

    Table 112. Biomérieux Sa Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Biomérieux Sa Molecular Diagnostics Systems Product

    Table 114. Biomérieux Sa Recent Developments/Updates

    Table 115. Cepheid Inc Corporation Information

    Table 116. Cepheid Inc Description and Business Overview

    Table 117. Cepheid Inc Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Cepheid Inc Molecular Diagnostics Systems Product

    Table 119. Cepheid Inc Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Molecular Diagnostics Systems Distributors List

    Table 123. Molecular Diagnostics Systems Customers List

    Table 124. Molecular Diagnostics Systems Market Trends

    Table 125. Molecular Diagnostics Systems Market Drivers

    Table 126. Molecular Diagnostics Systems Market Challenges

    Table 127. Molecular Diagnostics Systems Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Molecular Diagnostics Systems

    Figure 2. Global Molecular Diagnostics Systems Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Molecular Diagnostics Systems Market Share by Type in 2022 & 2029

    Figure 4. PCR Product Picture

    Figure 5. Hybridization Product Picture

    Figure 6. DNA Sequencing Product Picture

    Figure 7. Global Molecular Diagnostics Systems Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Molecular Diagnostics Systems Market Share by Application in 2022 & 2029

    Figure 9. Hospitals

    Figure 10. Laboratories

    Figure 11. Global Molecular Diagnostics Systems Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Molecular Diagnostics Systems Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Molecular Diagnostics Systems Sales (2018-2029) & (K Units)

    Figure 14. Global Molecular Diagnostics Systems Average Price (USD/Unit) & (2018-2029)

    Figure 15. Molecular Diagnostics Systems Report Years Considered

    Figure 16. Molecular Diagnostics Systems Sales Share by Manufacturers in 2022

    Figure 17. Global Molecular Diagnostics Systems Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Molecular Diagnostics Systems Players: Market Share by Revenue in 2022

    Figure 19. Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Molecular Diagnostics Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Molecular Diagnostics Systems Sales Market Share by Country (2018-2029)

    Figure 22. North America Molecular Diagnostics Systems Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Molecular Diagnostics Systems Sales Market Share by Country (2018-2029)

    Figure 26. Europe Molecular Diagnostics Systems Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Molecular Diagnostics Systems Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Molecular Diagnostics Systems Revenue Market Share by Region (2018-2029)

    Figure 34. China Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. China Taiwan Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Molecular Diagnostics Systems Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Molecular Diagnostics Systems Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Molecular Diagnostics Systems Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Molecular Diagnostics Systems Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. UAE Molecular Diagnostics Systems Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Molecular Diagnostics Systems by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Molecular Diagnostics Systems by Type (2018-2029)

    Figure 55. Global Molecular Diagnostics Systems Price (USD/Unit) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Molecular Diagnostics Systems by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Molecular Diagnostics Systems by Application (2018-2029)

    Figure 58. Global Molecular Diagnostics Systems Price (USD/Unit) by Application (2018-2029)

    Figure 59. Molecular Diagnostics Systems Value Chain

    Figure 60. Molecular Diagnostics Systems Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed